Susquehanna International Group, LLP Biora Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2022 Feb 14, 2023	SELL	$0.13 - $12.03 $27,833 - $2.58 Million	-214,100 Reduced 34.91%	399,200 $51,000
Q3 2022 Nov 14, 2022	SELL	$0.53 - $13.3 $82,521 - $2.07 Million	-155,700 Reduced 20.25%	613,300 $294,000
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.22 $72,800 - $158,600	-130,000 Reduced 14.46%	769,000 $538,000
Q1 2022 May 16, 2022	SELL	$1.11 - $2.25 $1.05 Million - $2.13 Million	-947,200 Reduced 51.31%	899,000 $1.04 Million
Q4 2021 Feb 14, 2022	BUY	$1.35 - $4.89 $1.47 Million - $5.33 Million	1,089,800 Added 144.08%	1,846,200 $3.86 Million
Q3 2021 Nov 15, 2021	BUY	$0.67 - $3.41 $491,981 - $2.5 Million	734,300 Added 3322.62%	756,400 $1.15 Million
Q2 2021 Aug 11, 2021	BUY	$2.11 - $4.93 $16,246 - $37,961	7,700 Added 53.47%	22,100 $79,000
Q1 2021 May 17, 2021	BUY	$3.91 - $7.31 $56,304 - $105,264	14,400 New	14,400 $69,000

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $342M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.